Related Experiment Video

Updated: May 25, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Diagnosis of cardiovascular disease in patients with chronic kidney disease

Peter A McCullough1, Hadeel Assad

  • 1St. John Providence Health System, Providence Hospital and Medical Centers, Providence Park Heart Institute, Novi, MI 48374, USA.

Blood Purification
|January 25, 2012
PubMed

Insights

Patients with chronic kidney disease (CKD) often develop severe cardiovascular diseases. Early diagnosis and intervention are crucial for managing this common comorbidity and improving patient outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular diseases (CVD) are highly prevalent in patients with chronic kidney disease (CKD).
  • The incidence and severity of CVD, including coronary atherosclerosis, valvular disease, myocardial dysfunction, and arrhythmias, increase with CKD progression.
  • Combined heart and kidney disease present significant diagnostic and management challenges.

Purpose of the Study:

  • To explore the early diagnosis of heart disease in patients with CKD.
  • To emphasize the importance of early intervention for managing cardiovascular comorbidities in CKD.
  • To reduce the impact of combined cardiovascular and kidney disease.

Main Methods:

  • This paper reviews existing literature and clinical data on the intersection of CKD and cardiovascular disease.
  • It focuses on the diagnostic challenges and potential early detection strategies.
  • The review highlights the link between CKD progression and CVD severity.

Main Results:

  • Cardiovascular diseases are frequently observed in CKD patients, often worsening as kidney function declines.
  • Terminal events in CKD commonly involve cardiovascular complications.
  • Early detection of heart disease in CKD patients is critical for timely management.

Conclusions:

  • There is a significant overlap between chronic kidney disease and cardiovascular disease.
  • Early diagnosis of cardiac conditions in CKD patients is essential for effective management.
  • Interventions aimed at early diagnosis can mitigate the adverse effects of this comorbidity.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...